Introducing hepatitis B vaccine in preadolescents meant a decline in the disease incidence rate by 52 percent, according to a study in which the University of Barcelona (UB) took part. The study analysed the efficiency and ...
Mar 14, 2019
0
2
(HealthDay)—Higher intake of whole grains may be associated with a lower risk for hepatocellular carcinoma (HCC) among U.S. adults, according to a study published online Feb. 21 in JAMA Oncology.
Mar 4, 2019
0
10
Analysing the levels of a protein called TonEBP could provide valuable insight into the likelihood of recurrence of hepatocellular carcinoma, an aggressive cancer of the liver, following its surgical removal. Drugs that target ...
Feb 20, 2019
0
2
The first prospective, longitudinal study investigating treatment of chronic hepatitis C with direct-acting antivirals finds that the treatment is associated with reduced risk of mortality and liver cancer, according to a ...
Feb 12, 2019
0
8
(HealthDay)—In patients with cirrhosis, frailty is more frequently observed in those with ascites or hepatic encephalopathy (HE) and is independently associated with liver transplant wait-list mortality, according to a ...
Feb 4, 2019
0
0
A research team based at Tokyo Medical and Dental University (TMDU) has used an integrated data analysis to classify hepatocellular carcinoma, the most common type of liver cancer, into three distinct subgroups, which should ...
Feb 4, 2019
0
0
An international team of researchers has identified a novel route that regulates the signaling pathways induced by extracellular matrix (ECM). This may serve as a new diagnostic marker and therapeutic target in the fight ...
Jan 21, 2019
0
0
(HealthDay)—Late recurrence after hepatocellular carcinoma (HCC) resection is associated with sex, cirrhosis, and several aggressive tumor characteristics of the initial HCC, according to a study recently published in JAMA ...
Dec 14, 2018
0
0
(HealthDay)—Both hospitalizations and deaths are increasing among Medicare recipients with liver cancer, according to a study presented at The Liver Meeting, the annual meeting of the American Association for the Study ...
Nov 19, 2018
0
0
(HealthDay)—Combined treatment with glecaprevir and pibrentasvir (G/P) is highly effective in treating chronic hepatitis C virus (HCV) genotype-1 infections that failed to respond to direct-acting antiviral therapy, according ...
Nov 15, 2018
0
0
